The underlying principle is that radiation-killed tumor cells release TAAs/TSAs and “danger-associated molecular patterns,” which may attract DCs to initiate TAA/TSA-specific CD8+ T-cell responses, thus enhancing objective responses and improving survival outcomes [136,139]. The gene discussed is CD8A; the disease is neoplasm.